Recombinant Prion Protein Seeded Conversion for Rapid Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting prion proteins, such as protein misfolding cyclic amplification (PMCA), are slow and require brain-derived substrates, limiting their sensitivity and practicality for rapid detection of prion diseases.
Innovation Solution
An ultrasensitive method using recombinant PrP-sen as a substrate for seeded polymerization, including rPrP-PMCA and QUIC assays, which agitate reactions by shaking instead of sonication, allowing for faster and more sensitive detection of prion protein misfolding without the need for brain-derived substrates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional PMCA methods using brain-derived substrates are used, then detection sensitivity is maintained, but detection time is prolonged (weeks) and operational complexity increases
Solution Approach 1:
The patent replaces expensive, complex brain-derived substrates with inexpensive, easily produced recombinant prion proteins (rPrP-sen). These recombinant proteins can be rapidly synthesized in large quantities using standard molecular biology techniques, eliminating the need for prolonged incubation periods and complex substrate preparation while maintaining detection sensitivity
Solution Approach 2:
The patent replaces the biological complexity of brain-derived substrates with a simplified recombinant protein system. By using r_prP-sen expressed in bacterial or eukaryotic systems, the method substitutes complex biological matrices with controlled, purified protein preparations, thereby reducing detection time and operational complexity
2Measurement precision
If brain-derived substrates are used for PMCA, then prion detection sensitivity is achieved, but ease of manufacture and operational simplicity are reduced
Solution Approach 1:
The patent replaces expensive, complex brain-derived substrates with inexpensive, easily produced recombinant prion proteins (rPrP-sen). These recombinant proteins can be rapidly synthesized in large quantities using standard molecular biology techniques, eliminating the need for prolonged incubation periods and complex substrate preparation while maintaining detection sensitivity
Solution Approach 2:
The patent extracts the essential functional component (prion protein substrate) from complex brain tissue and isolates it as a purified recombinant product. This extraction eliminates unnecessary biological complexity while retaining the essential substrate function needed for prion detection
3Productivity
If sonication is used to agitate aggregates in PMCA, then amplification efficiency is improved, but false positives increase and operational complexity increases
Solution Approach 1:
The patent replaces sonication (acoustic energy) with shaking (mechanical energy) for aggregate agitation. This substitution eliminates the high-energy acoustic fields that can cause non-specific protein denaturation and aggregation, thereby reducing false positives while maintaining sufficient amplification efficiency through gentler mechanical mixing
Solution Approach 2:
The patent uses shaking, which provides partial agitation compared to intense sonication, but this partial action is sufficient for the recombinant prion substrate system. The gentler shaking avoids excessive energy input that causes false positives, while still achieving adequate aggregate disruption for amplification
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables rapid detection of prion diseases, reducing the time required for diagnosis from weeks to days, while maintaining high sensitivity and reducing false positives, allowing for early detection and prevention of prion transmission.
Implementation Method 1
Detection of infectious prion protein by seeded conversion of recombinant prion protein
Implementation Method 2
the conversion of the rPrP-sen to the rPrP-res (Sc)
Implementation Method 3
agitating any aggregates formed during step (i)
Data Source
Figure 1A~1B
Figure 1C~1D
Figure 2A~2B
AI summary
The present disclosure relates to methods and compositions for the detection of infectious proteins or prions in samples, including the diagnosis of prion related diseases. One embodiment is an ultrasensitive method for detecting PrP-res (PrPSc) that allows the use of recombinant PrP-sen (rPrP-sen) as a substrate for seeded polymerization. A sample is mixed with purified rPrP-sen to make a reaction mix which is incubated to permit aggregation of the rPrP-sen with the PrP-res that may be present in the sample. Any aggregates are intermittently disaggregated by agitation (for example by sonication) and the reaction allowed to proceed to amplify target substrate. Any rPrP-res(Sc) in the reaction mix is detected to indicate the presence of PrP-res in the original sample. This assay, which is called rPrP-PMCA, is surprisingly much faster than existing PMCA methods, yet it still retains sufficient sensitivity to detect extremely low levels of PrP-res. An alternative of rPrP-PMCA is the QUIC method in which shaking of the reaction mixture is substituted for sonication. The surprising speed and efficiency of the method permits the rapid identification and diagnosis of prion disease, which can limit the transmission of prion diseases, particularly through the food supply.